BlackRock Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $244K | Buy |
38,500
+614
| +2% | +$3.89K | ﹤0.01% | 2551 |
|
|
2016
Q3 | $167K | Buy |
37,886
+4,772
| +14% | +$21K | ﹤0.01% | 2712 |
|
|
2016
Q2 | $94K | Buy |
33,114
+1,809
| +6% | +$5.14K | ﹤0.01% | 2944 |
|
|
2016
Q1 | $89K | Buy |
31,305
+823
| +3% | +$2.34K | ﹤0.01% | 2916 |
|
|
2015
Q4 | $315K | Sell |
30,482
-15,158
| -33% | -$157K | ﹤0.01% | 2297 |
|
|
2015
Q3 | $520K | Sell |
45,640
-314,953
| -87% | -$3.59M | ﹤0.01% | 2135 |
|
|
2015
Q2 | $5.38M | Buy |
360,593
+10,798
| +3% | +$161K | 0.01% | 953 |
|
|
2015
Q1 | $3.16M | Buy |
349,795
+6,689
| +2% | +$60.4K | ﹤0.01% | 1051 |
|
|
2014
Q4 | $4.17M | Sell |
343,106
-1,893
| -0.5% | -$23K | ﹤0.01% | 999 |
|
|
2014
Q3 | $3.38M | Sell |
344,999
-22,891
| -6% | -$224K | ﹤0.01% | 1031 |
|
|
2014
Q2 | $4.69M | Buy |
367,890
+357,957
| +3,604% | +$4.56M | ﹤0.01% | 964 |
|
|
2014
Q1 | $105K | Hold |
9,933
| – | – | ﹤0.01% | 2982 |
|
|
2013
Q4 | $75K | Buy |
9,933
+1,226
| +14% | +$9.26K | ﹤0.01% | 3127 |
|
|
2013
Q3 | $63K | Buy |
8,707
+468
| +6% | +$3.39K | ﹤0.01% | 3114 |
|
|
2013
Q2 | $13K | Buy |
+8,239
| New | +$13K | ﹤0.01% | 3340 |
|